SCHEMBL28359066

SCHEMBL28359066

NC(=O)c1nnc(-c2c(F)cccc2F)cc1Nc1cnn(CC2CNC2)c1

nearest known ligand 0.49

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 10/20 0.49
▸ JAK2 O60674 9/20 0.49
▸ JAK1 P23458 9/20 0.49
▸ JAK3 P52333 9/20 0.49
▸ RORC P51449 3/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28362626 0.89 JAK1 (0.49) TYK2JAK2JAK1JAK3RORC
SCHEMBL29552173 0.88 TYK2 (0.48) TYK2JAK2JAK1JAK3RORC
SCHEMBL29553135 0.86 JAK2 (0.39) TYK2JAK2JAK1JAK3RORC
SCHEMBL28359374 0.83 JAK2 (0.44) TYK2JAK2JAK1JAK3RORC
SCHEMBL28359221 0.80 JAK3 (0.52) TYK2JAK2JAK1JAK3PIM1
SCHEMBL29551832 0.80 TYK2 (0.37) TYK2JAK2JAK1JAK3RORC
SCHEMBL29551888 0.76 JAK2 (0.59) TYK2JAK2JAK1JAK3
SCHEMBL28362532 0.75 JAK2 (0.51) TYK2JAK2JAK1JAK3RORC
SCHEMBL29552249 0.73 TYK2 (0.58) TYK2JAK2JAK1JAK3
SCHEMBL28359236 0.73 TYK2 (0.58) TYK2JAK2JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback